돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 51606생성일: 2026년 10월 23일

Acetic Acid → HCID 178484155, 화합물

https://huagongshe.com/ko/reaction/51606

반응식

참여 물질

역할이름HCID투입량
반응물Acetic AcidHCID 176—
반응물Sodium BicarbonateHCID 516892—
반응물(3R)-(+)-3-(Dimethylamino)pyrrolidineHCID 2758521—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물Protein kinase inhibitor 9HCID 22736171—
용매1,2-DichloroethaneHCID 11—
용매MethanolHCID 887—
용매WaterHCID 962—
용매DichloromethaneHCID 6344—
생성물HCID 178484155HCID 178484155—
생성물HCID 178484156HCID 178484156—

반응 단계

A mixture of 4-[4-amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanone (100 g, 2.51 mmol), (3R)-(+)-3-(dimethylamino)pyrrolidine (0.86 g, 7.5 mmol), and acetic acid (0.43 mL, 7.5 mmol) in 1,2-dichloroethane (45 mL) was stirred at ambient temperature under an atmosphere of nitrogen for 30 minutes. Sodium triacetoxyborohydride (0.689 g, 3.26 mmol) was added and the mixture stirred at ambient temperature for 22 hours. Water (50 mL) and sodium bicarbonate (1.35 g, 16.1 mmol) were added and the mixture was stirred for 3 hours. The reaction mixture was transferred to a separatory funnel and the organic layer was separated. The aqueous layer was extracted with CH2Cl2(20 mL), and the combined organic extracts were dried over magnesium sulfate, filtered, and the solvent removed under reduced pressure to yield a red oil. The cis and trans isomers were purified by flash chromatography on silica gel (1 L 5% MeOH in CH2Cl2, then 1 L 10% MeOH in CH2Cl2, 1 L 20% MeOH in CH2Cl2, 1 L 30% MeOH in CH2Cl2, 1 L 40% MeOH in CH2Cl2, and 1 L 50% MeOH in CH2Cl2) to yield cis-7-{4-[(3R)-3-(dimethylamino)tetrahydro-1H-1-pyrrolyl]cyclohexyl}-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine as a pink solid (0.558 g, 1.12 mmol) and trans-7-{4-[(3R)-3-(dimethylamino)tetrahydro-1H-1-pyrrolyl]cyclohexyl}-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine as a pink solid (0.210 g, 0.422 mmol). The cis-7-{4-[(3R)-3-(dimethylamino)tetrahydro-1H-1-pyrrolyl]cyclohexyl}-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (0.330 g, 0.670 mmol) was dissolved in warm ethanol (5 mL) then maleic acid (0.233 g, 2.01 mmol) in ethanol (5 mL) was added. The mixture was cooled to ambient temperature and the solid was collected by filtration and dried to give cis-7-{4-[(3R)-3-(dimethylamino)tetrahydro-1H-1-pyrrolyl]cyclohexyl}-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine trimaleate salt (0.622 g) as a beige solid: 1H NMR (d6 DMSO, 400 MHz): δ H 8.20(1H, s), 7.41-7.48(4H, m), 7.35(1H, s), 7.08-7.19 (5H, m), 6.45(2H, bs), 6.16(6H, s), 4.70(1H, m), 4.30(2H, bs), 3.80(1H, bs), 3.08(3H, m), 2.76(6H, s), 2.00-2.21(6H, m), 1.74-1.72(4H, m); RP-HPLC (Delta Pak C18, 5 μm, 300 A, 15 cm; 5%-85% acetonitrile-0.1M ammonium acetate over 20 min, 1 mL/min) Rt 13.94 min. MS: MH+ 497.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06713474B2
출처 데이터셋uspto-grants-2004_03
ORD IDord-c50da85508b44a0487c41400b3d84cff
출처 메모uspto-grants-2004_03